CASE STUDIES
BES is top choice for Indivior B
ES, the specialist in design and fi t-out of clean rooms and specialist pharmaceutical facilities, has recently been awarded a £4m project to create a new production facility for opioid addiction treatment specialist,
Indivior.
Designed by BES to complement the existing assets at Indivior’s pharma campus in Hull, the new plant forms part of business continuity planning at Indivior, ensuring the company can continue to meet demand while providing the highest standards of health and safety for employees. The facility will be ATEX Zone 22/2 rated, requiring all elements of the
specifi cation to minimise the safety and operational hazards associated with the high explosion risk environment where hydrogen reactors are an integral part of the manufacturing process.
BES’s success in winning the contract to design and construct the new facilities builds on an existing relationship between the two companies, which saw BES complete a £20m research and development facility for Indivior three months ahead of schedule last year.
BES began the design process for the new plant by carrying out a full assessment of Indivior’s requirements and reviewing the accommodation currently used for the seven-stage chemical process involved in production. As part of the business continuity planning strategy, the new building has been designed to allow installation of eight hydrogen reactors, with three of these due for installation at fi t-out and the addition of the remaining fi ve scheduled over the next two years.
Dale Owen, design lead on the project at BES, said: “This project builds on the experience of designing and constructing ATEX-certifi ed facilities within the BES team, which involves ensuring that every element of the specifi cation
is anti-sparking or intrinsically safe. It also involves designing the facility to minimise the impact of any explosion in terms of both health and safety risk and isolation of hazards to localise any unavoidable damage. “We have carefully considered the commercial, operational and insurance requirements of the project to design a facility that is as safe and effi cient as possible, while answering all safety and hazard isolation validation requirements.”
To help manage the risk of the process critical hydrogen reactors, BES has designed each reactor booth with pressure-resistant panels on three walls and the soffi t, while the external wall will automatically release vents if pressure should increase to explosion hazard levels, thanks to an ingenious magnetised design. Each booth is also contained within a two-hour fi re- rated environment, ensuring that the damage and safety implications of any incidents can be contained.
The design has been agreed by Indivior and passed by a Dangerous Substances and Explosive Atmospheres (DSEAR) consultant, with fi t out due to begin by the end of the year.
Adrian Young, project manager at Indivior added: “BES exceeded our expectations during the research and development facility project and we have been impressed once again by the niche expertise within the business and the attention to detail across the team. They have even considered operational factors such as the height of diff erent operatives and how that will aff ect their fi eld of vision from the production facility fl oor.
“Our investment in this facility is a vital part of our business continuity planning and we are looking forward to seeing it become operational next year.”
58 October 2018
www.acr-news.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104
